I now have comprehensive, high-quality content from multiple authoritative sources. Let me compile the full response.
Management of Shock
Definition
Circulatory shock is generalized inadequate blood flow through the body to the extent that tissues are damaged - primarily because too little oxygen and nutrients are delivered to cells. Once established, it tends to be self-perpetuating: the cardiovascular system itself (myocardium, vessel walls, vasomotor centers) begins to deteriorate, driving progressive worsening. - Guyton and Hall Textbook of Medical Physiology
Classification
Shock is classified into four main categories, each with a distinct pathophysiologic mechanism:
| Type | Mechanism | Common Causes |
|---|
| Hypovolemic | Reduced circulating volume | Hemorrhage, burns, GI losses, dehydration, third-spacing |
| Distributive | Peripheral vasodilation / maldistribution of flow | Sepsis, anaphylaxis, neurogenic, adrenal crisis |
| Cardiogenic | Pump failure | MI, arrhythmia, cardiomyopathy, valve dysfunction |
| Obstructive | Mechanical impedance to flow | Tension pneumothorax, cardiac tamponade, massive PE, critical AS |
Rosen's EM further organizes this into five treatment-oriented categories: (1) volume infusion alone, (2) volume + vasopressor, (3) inotropic support/reversal of pump failure, (4) rate correction (arrhythmia), and (5) immediate relief of obstruction. - Rosen's Emergency Medicine, 10th ed.
Hemorrhagic Shock - ATLS Classification
| Class | Blood Loss (mL) | % Volume | HR | BP | Pulse Pressure | RR | Urine Output | Mental Status | Initial Fluid |
|---|
| I | Up to 750 | <15% | <100 | Normal | Normal/↑ | 14-20 | >30 mL/hr | Slightly anxious | Crystalloid |
| II | 750-1500 | 15-30% | >100 | Normal | ↓ | 20-30 | 20-30 mL/hr | Mildly anxious | Crystalloid |
| III | 1500-2000 | 30-40% | >120 | ↓ | ↓ | 30-40 | 5-15 mL/hr | Anxious, confused | Crystalloid + blood |
| IV | >2000 | >40% | >140 | ↓ | ↓ | >35 | Negligible | Confused, lethargic | Crystalloid + blood |
Note: HR and BP are notoriously variable in hemorrhage - no firm conclusion about the presence or severity of shock can be drawn from vital signs alone. - Goldman-Cecil Medicine
General Principles of Management
A key principle: treat circulatory shock simultaneously with efforts to determine its etiology. Do not wait for a diagnosis to begin resuscitation. The entire multidisciplinary team (physicians, nurses, pharmacists, respiratory therapists) must be engaged immediately. - Harrison's Principles of Internal Medicine, 22E (2025)
Step-by-Step Initial Management
1. Airway and Oxygenation
- Apply supplemental oxygen, titrate to maintain SpO2 92-95%
- If the patient cannot maintain adequate respiratory compensation for metabolic acidosis, or if hypoxemia is severe, proceed with intubation and mechanical ventilation
- Use lung-protective strategies: low tidal volume (6 mL/kg IBW), optimize PEEP, daily sedation holidays - Harrison's 22E
2. Vascular Access and Monitoring
- Place two large-bore peripheral IV catheters (16 or 18 gauge) for initial resuscitation
- If vasopressors are needed or volume resuscitation is inadequate, place a central venous catheter (CVC) - provides CVP monitoring and central venous O2 saturation (ScvO2), a surrogate for mixed venous saturation
- Arterial line for continuous MAP measurement, pulse/systolic pressure variation (volume responsiveness), and repeated ABG/lactate sampling (peripheral oximetry is unreliable in hypoperfusion states)
- Urinary catheter for hourly urine output monitoring as a marker of renal perfusion
- In cardiac arrest or critical illness, intraosseous access is the fastest route when IV access fails
- If cardiogenic shock is suspected and more detailed hemodynamics are needed, a Swan-Ganz catheter (measuring PCWP, CO, SVR) may be placed - Harrison's 22E
3. Point-of-Care Ultrasound (POCUS)
POCUS helps determine shock etiology rapidly:
- Cardiac windows: LV function (cardiogenic vs distributive), pericardial effusion/tamponade
- IVC collapsibility: Collapsible IVC in a spontaneously breathing patient at end-expiration suggests reduced intravascular volume
- Pleural space: Pneumothorax (more sensitive than CXR), pleural effusion
- Abdomen: Free fluid suggesting hemorrhage or infection
- Lower extremity veins: DVT, raising suspicion for PE
Limitation: performance and interpretation are operator-dependent. A 2018 RCT of 253 ED patients did not show a 30-day survival benefit from POCUS-guided management of undifferentiated shock. - Harrison's 22E
4. Fluid Resuscitation
Crystalloids vs Colloids
- Crystalloids are first-line (normal saline or balanced solutions such as Lactated Ringer's / Plasmalyte)
- Colloids (albumin, starches) have not been shown superior to crystalloids for survival in critical illness; modern evidence favors balanced crystalloid solutions over 0.9% saline (associated with less hyperchloremic acidosis and renal injury)
- In hemorrhagic shock: whole blood is optimal; plasma is an acceptable substitute when whole blood is unavailable; dextran solutions provide colloidal oncotic support - Guyton & Hall
By Shock Type:
- Hypovolemic/distributive: Aggressive volume resuscitation is first-line; 30 mL/kg IV crystalloid bolus is recommended in septic shock per Surviving Sepsis Campaign
- Cardiogenic shock: Volume must be used cautiously - aggressive fluid administration risks worsening pulmonary edema. Transfusion threshold is 8 g/dL (same safety as 10 g/dL in AMI patients) but the patient must be monitored carefully for worsening failure - Goldman-Cecil Medicine
- Septic shock: Transfuse packed red blood cells at Hb <7 g/dL (as effective as 9 g/dL threshold); no routine role for platelets or other blood products in resuscitation
- Volume reassessment: As the patient evolves (e.g., develops ARDS or renal failure), the fluid strategy must be adjusted - volume removal may then be appropriate - Harrison's 22E
In vasodilatory shock: Permissive hypotension targeting MAP ≥60 mmHg is acceptable rather than targeting higher pressures with more aggressive fluid loading, which yields similar outcomes. - Goldman-Cecil
5. Vasopressors and Inotropes
Initiate when intravascular volume is optimized but hypotension and tissue hypoperfusion persist.
| Agent | Receptor | Shock Type | Notes |
|---|
| Norepinephrine | α + β | First-line for septic/distributive shock | Potent vasoconstriction (α) + mild inotropy (β). Preferred over dopamine - less arrhythmia, lower mortality in cardiogenic subgroup (SOAP II trial) |
| Vasopressin | V1 (vasopressin R) | Second agent in septic shock | Corrects relative vasopressin deficiency; safe as add-on to norepinephrine; may benefit less severely ill patients |
| Epinephrine | α + β (dose-dependent) | Anaphylaxis (first-line IM); rescue vasopressor | Higher doses: tachyarrhythmia, myocardial ischemia, decreased splanchnic flow, metabolic acidosis |
| Dobutamine | β1 >> β2 | First-line for cardiogenic shock | Positive inotropy + mild vasodilation (decreased afterload); can be combined with norepinephrine in mixed distributive/cardiogenic shock |
| Dopamine | Dose-dependent DA/β/α | Avoid as first-line | No survival benefit over norepinephrine; increased arrhythmias; higher mortality in cardiogenic shock subgroup |
Key principle: vasopressors increase afterload, so adequate volume resuscitation must precede or accompany their initiation to optimize efficacy. - Harrison's 22E; Goldman-Cecil Medicine
6. Antibiotic Therapy (Septic Shock)
- Sepsis is the most common cause of shock
- Every hour of delay in appropriate antibiotics is associated with increased mortality
- Obtain appropriate cultures (blood cultures x2 sets, urine, respiratory) before starting antibiotics - but inability to obtain cultures must not delay treatment
- Start broad-spectrum antibiotics as soon as septic shock is suspected
- When sepsis is excluded, practice antibiotic stewardship and discontinue antibiotics promptly - Harrison's 22E
7. Cause-Specific (Tailored) Interventions
| Etiology | Specific Intervention |
|---|
| Anaphylaxis | Remove allergen, IM epinephrine (first-line), IV fluids, antihistamines, steroids |
| Septic shock | Broad-spectrum antibiotics, source control (drainage/debridement), vasopressors, consider hydrocortisone in refractory shock |
| Cardiogenic - AMI | Emergency revascularization (PCI/CABG), intra-aortic balloon pump or mechanical circulatory support (Impella/ECMO) |
| Cardiogenic - arrhythmia | ACLS algorithms, cardioversion, or temporary pacemaker |
| Cardiogenic - valve dysfunction | Emergency surgery |
| Hemorrhagic shock | Surgical hemostasis, endoscopy, interventional radiology; damage control resuscitation (balanced ratios of pRBC:FFP:platelets) |
| Cardiac tamponade | Emergency pericardiocentesis or surgical drainage |
| Tension pneumothorax | Immediate needle decompression, then chest tube |
| Massive PE | Systemic thrombolysis, catheter-directed therapy, surgical embolectomy |
| Adrenal insufficiency | IV stress-dose hydrocortisone (100 mg bolus then 200 mg/day infusion) |
| Aortic dissection | Emergency surgical repair (Type A) |
| Neurogenic shock | Volume + vasopressors (phenylephrine preferred to avoid tachycardia); maintain spinal perfusion pressure |
- Harrison's 22E; Rosen's Emergency Medicine
8. Endpoints of Resuscitation
Treatment targets used to guide resuscitation:
- MAP ≥65 mmHg (≥60 mmHg may be acceptable in distributive shock)
- Urine output >0.5 mL/kg/hr
- Serum lactate normalization / clearance ≥10-20% (marker of tissue hypoperfusion resolving)
- ScvO2 ≥70% (surrogate for adequacy of oxygen delivery relative to demand)
- Improving mental status and skin perfusion (capillary refill, temperature)
- Decreasing base deficit (approaching 0)
- Resolution of tachycardia and return of normal pulse pressure
9. Irreversible Shock
When shock reaches a terminal stage, the circulatory system itself has deteriorated beyond recovery - myocardial depression, progressive acidosis, coagulopathy (DIC), and multi-organ failure. Prevention of irreversible shock requires early recognition and aggressive treatment. - Guyton & Hall
Monitoring
Continuous monitoring during shock resuscitation includes:
- Continuous ECG, pulse oximetry
- Arterial line for continuous MAP and repeated ABG
- CVP (central venous pressure)
- ScvO2 (central venous oxygen saturation)
- Hourly urine output
- Serial lactate measurements
- POCUS for dynamic assessment
Prognosis
Overall mortality from shock is approximately 25%. Prognostic indicators include:
- Response of blood pressure and cardiac output to resuscitation
- Trend in serum lactate
- Early development of multi-organ dysfunction (predictive of prolonged ICU course and higher mortality)
- Age, comorbidities, and the inciting event determine long-term outcomes
- Interestingly, acute features of shock (degree of hypotension) predict short-term mortality but are less predictive of long-term survival - Goldman-Cecil Medicine
Summary Algorithm
SHOCK RECOGNIZED (hypotension + tissue hypoperfusion)
|
▼
Simultaneous: Airway/O2 | IV Access | Monitor | Labs | ECG | CXR | POCUS
|
▼
Undifferentiated? → Start IV fluids + cultures + empiric antibiotics
|
├── HYPOVOLEMIC → Crystalloids ± blood products → Control bleeding
|
├── DISTRIBUTIVE → Fluids → Norepinephrine → Antibiotics (sepsis)
| Epinephrine (anaphylaxis) | Steroids (adrenal)
|
├── CARDIOGENIC → Judicious fluids → Dobutamine ± Norepinephrine
| Revascularize (AMI) | Mechanical support
|
└── OBSTRUCTIVE → Immediate decompression
Pericardiocentesis | Needle thoracostomy | Thrombolysis
Sources: Harrison's Principles of Internal Medicine 22E (2025) | Goldman-Cecil Medicine | Rosen's Emergency Medicine 10th Ed | Guyton & Hall Textbook of Medical Physiology | Surviving Sepsis Campaign Guidelines (Evans et al, Crit Care Med 2021)